Adjuvant systemic treatment for breast cancer.
Reizenstein
P
P
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004992:Ethics, Medical; D005260:Female; D006801:Humans; D011289:Preleukemia / Q000139:chemically induced
D000970:Antineoplastic Agents